To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval for its Alzheimer’s drug donanemab … Elders’ life expectancy shouldn’t top list of cancer screening priorities: study … Overlooked question on new Alzheimer’s drug: When should patients stop taking it? … Workers at 12 PA nursing homes cite sick time rules as part of vote to strike … NIH studying COVID immunity in vaccinated pregnant women and their infants … Leading clinician groups affirm COVID vaccine safety after heart inflammation findings
